
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Hoodia gordonii is a South African succulent containing the steroid glycoside P57, which suppresses appetite by mimicking glucose effects on hypothalamic neurons. This cactus-like plant helps reduce caloric intake and supports weight management through its direct action on brain hunger centers.

Reported Benefits (Provisional)
Origin & History

Hoodia gordonii is a succulent plant native to the Kalahari Desert in Southern Africa. It is traditionally harvested by the San people for its appetite-suppressing properties.
Research Narrative (Provisional)
Some studies suggest Hoodia gordonii may help reduce appetite, but evidence from large-scale clinical trials is limited and mixed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Hoodia gordonii is a succulent plant with a sparse conventional nutritional profile, as it is consumed in small therapeutic quantities rather than as a food staple. The primary bioactive compound is P57 (oxypregnane steroidal glycoside), estimated at approximately 0.1–1% of dry weight, which mimics glucose signaling in the hypothalamus to suppress appetite. It contains trace amounts of glycosides, flavonoids, and terpenes. Moisture content in fresh stems is approximately 90–92%. Minimal macronutrient contribution: carbohydrates ~3–5g per 100g dry weight, protein ~1–2g, fat <1g. Micronutrients are limited but include trace magnesium (~8–12mg/100g dry), potassium (~150–200mg/100g dry), and calcium (~20–30mg/100g dry). Fiber content is modest at ~2–4g per 100g dry weight from plant cell wall material. Bioavailability of P57 is notably limited by first-pass hepatic metabolism and poor oral absorption; lipid-based delivery systems or standardized extracts (typically standardized to 20:1 concentration) significantly improve P57 bioavailability. The steroidal glycoside structure requires intestinal enzymatic conversion for partial activation.
Reported Mechanism (Provisional)
Hoodia's active compound P57 (pregnane steroid glycoside) crosses the blood-brain barrier and acts on hypothalamic neurons in the appetite control center. P57 mimics the effect of glucose on these neurons, triggering satiety signals that reduce food intake. The compound increases ATP levels in hypothalamic cells, similar to the metabolic state after eating.
Clinical Narrative (Provisional)
Most human studies on Hoodia gordonii have been small-scale or industry-funded with mixed results. A 2011 randomized controlled trial with 49 overweight women showed modest appetite reduction but no significant weight loss over 12 weeks. Earlier studies suggested 400-800mg daily doses could reduce caloric intake by 25-30%, but larger independent trials are lacking. The evidence for weight loss effectiveness remains limited and inconclusive.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







